Leaflet DORZOPT 20mg / ml ophthalmic drops solution


Indicated for: glaucoma; ocular hypertension

Substance: dorzolamide (glaucoma agent)

ATC: S01EC03 (Sensory organs | Antiglaucoma preparations and miotics | Carbonic anhydrase inhibitors)

Dorzolamidum is a medication used for the treatment of glaucoma and ocular hypertension. It is a carbonic anhydrase inhibitor that reduces the production of aqueous humor, thereby lowering intraocular pressure.

The medication is available as eye drops and is usually administered two or three times daily, according to the doctor's instructions. It is effective in preventing optic nerve damage and preserving vision.

Side effects may include burning or stinging sensation in the eyes, bitter taste, dry eyes, and, in rare cases, allergic reactions. Regular monitoring of intraocular pressure is essential.

Consult your doctor to discuss the benefits and risks of treatment with Dorzolamidum. Follow the administration instructions to ensure treatment effectiveness.

General data about DORZOPT 20mg / ml

  • Substance: dorzolamide
  • Date of last drug list: 01-05-2026
  • Commercial code: W53830001
  • Concentration: 20mg / ml
  • Pharmaceutical form: ophthalmic drops solution
  • Quantity: 1
  • Product type: generic
  • Price: 18.99 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: ROMPHARM COMPANY S.R.L. - ROMANIA
  • Holder: ROMPHARM COMPANY S.R.L. - ROMANIA
  • Number: 13068/2020/01
  • Shelf life: 2 years;after the first opening of the bottle-28 days

Pharmaceutical forms available for dorzolamide

Concentrations available for dorzolamide

  • 20mg/5mg/ml
  • 20mg/ml

Combinations with other substances

Compensation lists for DORZOPT 20mg / ml Rompharm

G26 (C1) - Glaucoma

Price

Copayment

Patient

18.99 RON

18.99 RON

0.00 RON

GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)

Price

Copayment

Patient

18.99 RON

18.99 RON

0.00 RON